INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 418m ago
House PTR18m ago
SEC 13F17m ago
Robinhood Chain17m ago

Results

79,760 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
ZJ
Zheng Jie (James)Director, Chief Executive Officer
ASAmer Sports, Inc.
Option exercise
M—
33.4K sh
Apr 15, 2026Apr 15, 2026
Page 1201 of 1994
← PrevNext →
traded Apr 15, 2026
+0d
SEC Form 4

Evidence

9
AC
Ames Sophie CExec. Vice President & CHRO
QBTSD-Wave Quantum Inc.
Tax withholding
F$45K
3,180 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

9
SJ
Silverman JoshuaDirector, Executive Chairman
QCLSQ/C TECHNOLOGIES, INC.
Grant or award
A—
100.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

9
GM
Glass MitchellDirector, Chief Medical Officer
QCLSQ/C TECHNOLOGIES, INC.
Grant or award
A—
50.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

9
SK
Siu Hera KDirector
GTGOODYEAR TIRE & RUBBER CO /OH/
Option exercise
M—
9,523 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

9
NJ
Nelson Tyler JVP, Chief Financial Officer
OTTROtter Tail Corp
Grant or award
A—
800 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

9
NP
Nelson Jonathan PChief Operations Officer
BYNDBEYOND MEAT, INC.
Tax withholding
F$286
434 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

8
SD
Spector DavidDirector, Chairman & CEO
PFSIPennyMac Financial Services, Inc.
Open-market sale · 10b5-1 plan
SELL$889K
9,583 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

8
ML
Mater Tonya L.SVP & Chief Accounting Officer
EPREPR PROPERTIES
Open-market sale · 10b5-1 plan
SELL$112K
2,000 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

8
MM
Markovich John M.Chief Financial Officer
QBTSD-Wave Quantum Inc.
Tax withholding
F$123K
8,607 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

7
SM
Slessor MikeDirector, CEO
FORMFORMFACTOR INC
Open-market sale · 10b5-1 plan
SELL$698K
5,432 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

7
Siebel Thomas MDirector, Executive Chairman, 10% Owner
AIC3.ai, Inc.
Option exercise · 10b5-1 plan
M—
326.2K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

7
SM
Slessor MikeDirector, CEO
FORMFORMFACTOR INC
Open-market sale · 10b5-1 plan
SELL$302K
2,369 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

7
BL
Brooks Jayme L.Chief Financial Officer
LMBLimbach Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$487K
5,703 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

5
ND
Nguyen DianeEVP, Chief Legal Officer & GC
QBTSD-Wave Quantum Inc.
Tax withholding
F$58K
4,066 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

5
FM
Fordyce MarshallDirector, PRESIDENT AND CEO
VERAVera Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
900 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

4
HM
Hoffmann MartinCEO
ONONOn Holding AG
Open-market sale · 10b5-1 plan
SELL$141K
4,150 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

4
SM
Slessor MikeDirector, CEO
FORMFORMFACTOR INC
Open-market sale · 10b5-1 plan
SELL$114K
900 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

4
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Derivative conversion · 10b5-1 plan
C—
11.00M sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

4
Yuan Eric S.Director, Chief Executive Officer
ZMZoom Communications, Inc.
Derivative conversion · 10b5-1 plan
C—
69.9K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

4
ML
Mater Tonya L.SVP & Chief Accounting Officer
EPREPR PROPERTIES
Open-market sale · 10b5-1 plan
SELL$147K
2,600 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

4
SM
Slessor MikeDirector, CEO
FORMFORMFACTOR INC
Open-market sale · 10b5-1 plan
SELL$99K
767 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

4
CM
Craig Jonathan M.MD, Head of Retail Investing
SCHWSCHWAB CHARLES CORP
Option exercise · 10b5-1 plan
M$1.02M
21.8K sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

4
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
6,349 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

4
SM
Slessor MikeDirector, CEO
FORMFORMFACTOR INC
Open-market sale · 10b5-1 plan
SELL$229K
1,826 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

3
CM
Craig Jonathan M.MD, Head of Retail Investing
SCHWSCHWAB CHARLES CORP
Option exercise · 10b5-1 plan
M—
21.8K sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

2
PJ
Prober Charles J.Director
LIFLife360, Inc.
Option exercise · 10b5-1 plan
M$89K
7,930 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

1
SE
Susi Roger E.Director, CEO, President, Chairman, 10% Owner
IRMDIRADIMED CORP
Open-market sale · 10b5-1 plan
SELL$238K
2,564 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

1
SE
Susi Roger E.Director, CEO, President, Chairman, 10% Owner
IRMDIRADIMED CORP
Open-market sale · 10b5-1 plan
SELL$55K
589 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

1
SE
Susi Roger E.Director, CEO, President, Chairman, 10% Owner
IRMDIRADIMED CORP
Open-market sale · 10b5-1 plan
SELL$197K
2,107 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

1
SE
Susi Roger E.Director, CEO, President, Chairman, 10% Owner
IRMDIRADIMED CORP
Open-market sale · 10b5-1 plan
SELL$170K
1,847 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$59K
4,167 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
KL
Kutua LubiCFO, Treasurer
BYNDBEYOND MEAT, INC.
Tax withholding · 10b5-1 plan
F$797
1,208 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
900.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
16.7K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
27.1K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
SE
Susi Roger E.Director, CEO, President, Chairman, 10% Owner
IRMDIRADIMED CORP
Open-market sale · 10b5-1 plan
SELL$37K
393 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

0
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
3,542 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
100.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
CR
Cline Christopher R.CHIEF FINANCIAL OFFICER
TVTXTravere Therapeutics, Inc.
Grant or award · 10b5-1 plan
A—
14.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence